Challenges and opportunities for conceiving genetically diverse sickle cell mice

Area of Science:

• Hematology
• Genetics
• Disease Modeling

Background:

• Recent FDA approval of gene therapy for sickle cell disease (SCD) offers new treatment avenues.
• Current gene therapies for SCD may not be accessible to all patients due to cost and health concerns.
• Understanding SCD heterogeneity is vital for developing personalized pharmacological interventions.

Purpose of the Study:

• To discuss the challenges and opportunities in creating genetically diverse sickle cell mice (GDS mice).
• To highlight the importance of GDS mice in advancing SCD research.
• To explore how GDS mice can elucidate SCD outcome heterogeneity and anemia.

Main Methods:

• Development of humanized and genetically diverse mouse models.
• Association of candidate genotypes with hematological traits.
• Assessment of organ function and disease resilience in GDS mice.

Main Results:

• Genetically diverse sickle cell mice (GDS mice) are proposed as essential tools.
• These models are expected to complement existing SCD research approaches.
• GDS mice offer a pathway to better understand SCD heterogeneity and anemia.

Conclusions:

• Genetically diverse mouse models are critical for unraveling SCD complexity.
• GDS mice can significantly enhance the study of patient-specific SCD outcomes.
• Further development of GDS mice is needed to improve therapeutic strategies for sickle cell disease.